Muriel Siadak
About
In The Last Decade
Muriel Siadak
19 papers receiving 661 citations
Peers
Comparison fields: 5 of 82
- Hematology 458
- Immunology 229
- Oncology 172
- Epidemiology 119
- Genetics 96
Countries citing papers authored by Muriel Siadak
This map shows the geographic impact of Muriel Siadak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel Siadak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel Siadak more than expected).
Fields of papers citing papers by Muriel Siadak
This network shows the impact of papers produced by Muriel Siadak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel Siadak. The network helps show where Muriel Siadak may publish in the future.
Co-authorship network of co-authors of Muriel Siadak
This figure shows the co-authorship network connecting the top 25 collaborators of Muriel Siadak. A scholar is included among the top collaborators of Muriel Siadak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muriel Siadak. Muriel Siadak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 16 | |
| 3 | 9 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 8 | |
| 9 | 5 | |
| 10 | 65 | |
| 11 | 52 | |
| 12 | CARE-PARTNER: a computerized knowledge-support system for stem-cell post-transplant long-term follow-up on the World-Wide-Web. | 10 |
| 13 | 22 | |
| 14 | 15 | |
| 15 | 239 | |
| 16 | 12 | |
| 17 | A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. | 89 |
| 18 | 35 | |
| 19 | Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation. | 18 |
| 20 | Late complications of allogeneic and autologous marrow transplantation. | 83 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.